» Articles » PMID: 20169186

Six RNA Viruses and Forty-one Hosts: Viral Small RNAs and Modulation of Small RNA Repertoires in Vertebrate and Invertebrate Systems

Abstract

We have used multiplexed high-throughput sequencing to characterize changes in small RNA populations that occur during viral infection in animal cells. Small RNA-based mechanisms such as RNA interference (RNAi) have been shown in plant and invertebrate systems to play a key role in host responses to viral infection. Although homologs of the key RNAi effector pathways are present in mammalian cells, and can launch an RNAi-mediated degradation of experimentally targeted mRNAs, any role for such responses in mammalian host-virus interactions remains to be characterized. Six different viruses were examined in 41 experimentally susceptible and resistant host systems. We identified virus-derived small RNAs (vsRNAs) from all six viruses, with total abundance varying from "vanishingly rare" (less than 0.1% of cellular small RNA) to highly abundant (comparable to abundant micro-RNAs "miRNAs"). In addition to the appearance of vsRNAs during infection, we saw a number of specific changes in host miRNA profiles. For several infection models investigated in more detail, the RNAi and Interferon pathways modulated the abundance of vsRNAs. We also found evidence for populations of vsRNAs that exist as duplexed siRNAs with zero to three nucleotide 3' overhangs. Using populations of cells carrying a Hepatitis C replicon, we observed strand-selective loading of siRNAs onto Argonaute complexes. These experiments define vsRNAs as one possible component of the interplay between animal viruses and their hosts.

Citing Articles

Virus-derived siRNA: Coronavirus and influenza virus trigger antiviral RNAi immunity in birds.

Wu Y, Liu P, Zhou J, Fu M, Wang C, Xiong N Nucleic Acids Res. 2025; 53(4).

PMID: 39988316 PMC: 11840554. DOI: 10.1093/nar/gkaf116.


Enhanced RNAi does not provide efficient innate antiviral immunity in mice.

Kulmann M, Taborska E, Benkoova B, Palus M, Drobek A, Horvat F Nucleic Acids Res. 2025; 53(1.

PMID: 39778869 PMC: 11707545. DOI: 10.1093/nar/gkae1288.


Targeting viral suppressor of RNAi confers anti-coronaviral activity.

Chen J, Mu J, Zhou K, Zhang Y, Zhang J, Shu T Mol Ther. 2024; 33(1):201-214.

PMID: 39663700 PMC: 11764073. DOI: 10.1016/j.ymthe.2024.12.009.


Functions and applications of RNA interference and small regulatory RNAs.

Feng X, Guang S Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):119-130.

PMID: 39578714 PMC: 11802346. DOI: 10.3724/abbs.2024196.


Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.

Chen G, Han Q, Li W, Hai R, Ding S Proc Natl Acad Sci U S A. 2024; 121(17):e2321170121.

PMID: 38630724 PMC: 11046691. DOI: 10.1073/pnas.2321170121.


References
1.
Wilusz J, Kurilla M, Keene J . A host protein (La) binds to a unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc Natl Acad Sci U S A. 1983; 80(19):5827-31. PMC: 390168. DOI: 10.1073/pnas.80.19.5827. View

2.
OMalley R, Mariano T, Siekierka J, Mathews M . A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell. 1986; 44(3):391-400. DOI: 10.1016/0092-8674(86)90460-5. View

3.
de Vries W, Berkhout B . RNAi suppressors encoded by pathogenic human viruses. Int J Biochem Cell Biol. 2008; 40(10):2007-12. DOI: 10.1016/j.biocel.2008.04.015. View

4.
Joshua-Tor L . The Argonautes. Cold Spring Harb Symp Quant Biol. 2007; 71:67-72. DOI: 10.1101/sqb.2006.71.048. View

5.
Parameswaran P, Jalili R, Tao L, Shokralla S, Gharizadeh B, Ronaghi M . A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing. Nucleic Acids Res. 2007; 35(19):e130. PMC: 2095802. DOI: 10.1093/nar/gkm760. View